Expert Review of Pharmacoeconomics & Outcomes Research

Scope & Guideline

Bridging the Gap Between Research and Real-World Outcomes

Introduction

Welcome to your portal for understanding Expert Review of Pharmacoeconomics & Outcomes Research, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1473-7167
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2001 to 2024
AbbreviationEXPERT REV PHARM OUT / Expert Rev. Pharmacoecon. Outcomes Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The Expert Review of Pharmacoeconomics & Outcomes Research focuses on the critical evaluation of pharmacoeconomic studies and their implications for healthcare outcomes. Its scope encompasses a wide range of topics related to health economics, cost-effectiveness analysis, and the impact of healthcare interventions on patient outcomes.
  1. Pharmacoeconomics:
    The journal publishes comprehensive analyses of the economic aspects of drug therapies, including cost-effectiveness and budget impact analyses, to inform healthcare decision-making.
  2. Health Technology Assessment (HTA):
    Research on the methodologies and applications of HTA in evaluating the value of new health technologies, drugs, and interventions to guide policy and reimbursement decisions.
  3. Patient-reported Outcomes:
    Studies focusing on measuring and valuing health-related quality of life and patient-reported outcomes, which are critical for assessing the impact of treatments from the patient's perspective.
  4. Comparative Effectiveness Research:
    Analysis comparing the effectiveness, safety, and cost of different therapeutic interventions to provide evidence for clinical guidelines and policy-making.
  5. Digital Health and Innovation:
    Exploration of the economic implications of digital health technologies and innovations, including their role in improving medication adherence and patient outcomes.
  6. Global Health Economics:
    Research addressing pharmacoeconomic evaluations in various global contexts, particularly in low- and middle-income countries, to understand the broader implications of healthcare interventions.
The journal has seen a rise in interest in several emerging themes that align with contemporary challenges in pharmacoeconomics and healthcare delivery.
  1. Integration of Machine Learning and AI:
    There is a growing trend towards utilizing machine learning and artificial intelligence in health economic evaluations, offering novel approaches to predict outcomes and enhance decision-making.
  2. Value-Based Healthcare Models:
    An increased focus on value-based healthcare, with research exploring how to align reimbursement models with patient outcomes and overall healthcare value.
  3. Real-World Evidence (RWE):
    The importance of real-world evidence is gaining traction, with studies emphasizing the need to assess the effectiveness and economic impact of interventions in everyday clinical settings.
  4. Patient Engagement in Research:
    Emerging themes include the engagement of patients in the development of health economic evaluations, emphasizing the importance of incorporating patient preferences and experiences.
  5. Sustainability and Environmental Considerations:
    A new focus on incorporating sustainability metrics into health economic evaluations, addressing the environmental impact of healthcare interventions.
  6. Cross-Disciplinary Approaches:
    An increase in interdisciplinary research that combines insights from economics, public health, and clinical practice to address complex healthcare challenges.

Declining or Waning

While the journal has maintained a robust focus on pharmacoeconomics and health outcomes, certain themes appear to be waning in prominence based on recent publications.
  1. Traditional Cost-Utility Analyses:
    There is a noticeable decline in studies solely relying on traditional cost-utility analyses without integrating broader health economic perspectives or real-world evidence.
  2. Focus on Localized Studies:
    The emphasis on localized pharmacoeconomic studies is decreasing, with a shift towards more globally relevant research that can inform international health policies.
  3. Single Disease Focus:
    Research concentrating on singular diseases is becoming less common, as the journal increasingly favors studies that incorporate multi-condition perspectives or address comorbidities.
  4. Outdated Methodologies:
    There is a decline in the publication of studies utilizing outdated economic evaluation methodologies, as the field evolves towards more sophisticated and innovative approaches.
  5. Static Policy Evaluations:
    Research that merely evaluates existing policies without proposing actionable insights or innovations is becoming less prevalent, reflecting a need for more dynamic and forward-thinking analyses.

Similar Journals

Gesundheitsoekonomie und Qualitaetsmanagement

Transforming Healthcare through Economic Understanding and Quality Focus
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

American Journal of Health Economics

Empowering evidence-based health decisions.
Publisher: UNIV CHICAGO PRESSISSN: 2332-3493Frequency: 4 issues/year

The American Journal of Health Economics is a premier academic publication dedicated to advancing the understanding of the economic aspects of health and healthcare. Published by the University of Chicago Press, this journal has established itself as a vital resource for researchers, policymakers, and health professionals since its convergence in 2015. With an impressive Q1 ranking in key categories—including Economics, Health Policy, and Public Health—and a solid reputation in the academic community, it ranks in the top 20% for Economics and Health Policy in the Scopus database. The journal seeks to publish high-quality, peer-reviewed articles that contribute to the discourse on health economics, addressing critical issues like health disparities, policy evaluation, and the efficiency of healthcare systems. Although it does not offer open access, subscribers can access groundbreaking research that shapes health economic strategies and practices. As a trusted source in its field, the American Journal of Health Economics plays a crucial role in fostering evidence-based decision-making and enhancing the impact of economic research in healthcare.

Journal of Managed Care & Specialty Pharmacy

Elevating Standards in Pharmaceutical Science and Care
Publisher: ACAD MANAGED CARE PHARMACYISSN: 2376-0540Frequency: 12 issues/year

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.

Health Economics Review

Empowering decision-makers with robust economic evaluations.
Publisher: BMCISSN: 2191-1991Frequency: 1 issue/year

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.

Cost Effectiveness and Resource Allocation

Championing Open Access to Transform Healthcare Insights
Publisher: BMCISSN: 1478-7547Frequency: 1 issue/year

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

AMERICAN JOURNAL OF MANAGED CARE

Driving innovation in health policy and managed care.
Publisher: MANAGED CARE & HEALTHCARE COMMUNICATIONS LLCISSN: 1088-0224Frequency: 12 issues/year

AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.

Journal of Comparative Effectiveness Research

Enhancing clinical effectiveness with global perspectives.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

NURSING ECONOMICS

Exploring the Intersection of Nursing and Healthcare Economics.
Publisher: JANNETTI PUBLICATIONS, INCISSN: 0746-1739Frequency: 6 issues/year

Nursing Economics, published by Jannetti Publications, Inc, is a significant peer-reviewed journal that serves the nuanced intersection of healthcare economics and nursing. Operating under ISSN 0746-1739, this esteemed journal has been instrumental in advancing knowledge within the nursing profession since its inception in 1983, although its coverage was discontinued in Scopus as of 2021. With a focus on innovative research and practical applications, Nursing Economics addresses key issues in leadership and management within the nursing field, holding a Q3 quartile ranking in both Leadership and Management and Medicine (miscellaneous) as of 2023. Its Scopus rank within nursing leadership and management indicates a respectable position among its peers, demonstrating its relevance and contribution to the professional discourse. Researchers, practitioners, and students alike will find valuable insights and evidence-based perspectives that aim to enhance the practice and study of nursing economics in today’s evolving healthcare landscape.

MEDICAL DECISION MAKING

Elevating medical decisions with comprehensive analyses.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

Health Economics Policy and Law

Shaping Tomorrow’s Health Policies Through Rigorous Research
Publisher: CAMBRIDGE UNIV PRESSISSN: 1744-1331Frequency: 4 issues/year

Health Economics Policy and Law is a premier journal published by Cambridge University Press that focuses on the intersection of health economics, policy formulation, and legal frameworks. Since its establishment in 2006, the journal has been at the forefront of disseminating high-quality research, covering critical issues in the ever-evolving health policy landscape. With an impressive impact factor and ranked in the Q1 category of Health Policy according to the latest metrics (2023), it serves as a vital resource for academic researchers, professionals, and students alike. The journal aims to stimulate discussion and influence decision-making by providing rigorous empirical studies, policy analyses, and theoretical evaluations. While not open access, its publications are accessible through institutional subscriptions, reflecting its commitment to supporting scholarly discourse within the field. As it continues to converge towards its 2024 goals, Health Economics Policy and Law remains an essential platform for advancing knowledge and fostering innovation in health policy and law.